Transfer of phosphatidylethanol between lipoproteins

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 11, 2004, Pages 1638-1642

  Liisanantti, Marja K ^a   Huhta, Kimmo ^a   Savolainen, Markku J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Alcohol; CETP; Lipoproteins; Phosphatidylethanol; PLTP

Indexed keywords

ALCOHOL; BINDING PROTEIN; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; PHOSPHATIDYLETHANOL; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ADULT; AGAR GEL ELECTROPHORESIS; ALCOHOLISM; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CLINICAL ARTICLE; ELECTRICITY; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN METABOLISM;

ADULT; ALCOHOLISM; ANALYSIS OF VARIANCE; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; GLYCEROPHOSPHOLIPIDS; GLYCOPROTEINS; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED;

EID: 9244228571     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000145788.72810.D6     Document Type: Article

References (30)

1. Ailing C, Gustavsson L, Änggård E (1983) An abnormal phospholipid in rat organs after ethanol treatment. FEBS Lett 152:24-28.
2. Avduloy NA, Chochina SV, Igbavboa U, Wood WG (2000) Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol. Biochemistry 39:10599-10606.
3. Chajek T, Fielding CJ (1978) Isolation and characterization of a human serum cholesteryl ester transfer protein. Proc Natl Acad Sci USA 75:3445-3449.
4. de Grooth GJ, Kuivenhoven JA, Stalenhoef AF, de Graaf J, Zwinderman AH, Posma JL, van Tol A, Kastelein JJ (2002) Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation 105:2159-2165.
5. Durley RC, Grapperhaus ML, Massa MA, Mischke DA, Parnas BL, Fobian YM, et al. (2000) Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein. J Med Chem 43:4575-4578.
6. Eibl H, Kovatchev S (1981) Preparation of phospholipids and their analogs by phospholipase D. Methods Enzymol 72:632-639.
7. Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211-228.
8. Groener JE, Pelton RW, Kostner GM (1986) Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 32:283-286.
9. Hannuksela M, Marcel YL, Kesäniemi YA, Savolainen MJ (1992) Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 33:737-744.
10. Hannuksela ML, Liisanantti MK, Savolainen MJ (2002) Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis. Crit Rev Clin Lab Sci 39:225-283.
11. Hannuksela ML, Rärnet ME, Nissinen AE, Liisanantti MK, Savolainen MJ (2004) Effects of ethanol on lipids and atherosclerosis. Pathophysiology 10:93-103.
12. Hannuksela ML, Rantala M, Kesäniemi YA, Savolainen MJ (1996) Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins. Arterioscler Thromb Vasc Biol 16:213-221.
13. Hesler CB, Tall AR, Swenson TL, Weech PK, Marcel YL, Milne RW (1988) Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem 263:5020-5023.
14. Hirano K, Matsuzawa Y, Sakai N, Hiraoka H, Nozaki S, Funahashi T, Yamashita S, Kubo M, Tarui S (1992) Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity. Metabolism 41:1313-1318.
15. Hope HR, Heuvelman D, Duffin K, Smith C, Zablocki J, Schilling R, et al. (2000) Inhibition of cholesteryl ester transfer protein by substituted dithiobisnicotinic acid dimethyl ester: involvement of a critical cysteine. J Lipid Res 41:1604-1614.
16. Huuskonen J, Olkkonen VM, Jauhiainen M, Ehnholm C (2001) The impact of phospholipid transfer protein (PLTP) on HDL metabolism. Atherosclerosis 155:269-281.
17. Ito T, Nishiwaki M, Ishikawa T, Nakamura H (1995) CETP and LCAT activities are unrelated to smoking and moderate alcohol consumption in healthy normolipidemic men. Jpn Circ J 59:541-546.
18. Lagrost L, Athias A, Herbeth B, Guyard-Dangremont V, Artur Y, Paille F, Gambert P, Lallemant C (1996) Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J Biol Chem 271:19058-19065.
19. Liinamaa MJ, Hannuksela ML, Kesäniemi YA, Savolainen MJ (1997) Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol 17:2940-2947.
20. Liinamaa MJ, Kesäniemi YA, Savolainen MJ (1998) Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers. Ann Med 30:316-322.
21. Liisanantti MK, Hannuksela ML, Rärnet ME, Savolainen MJ (2004) Lipoprotein-associated phosphatidylethanol increases the plasma concentration of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 24:1037-1042.
22. Massa MA, Spangler DP, Durley RC, Hickory BS, Connolly DT, Witherbee BJ, Smith ME, Sikorski JA (2001) Novel heteroaryl replacements of aromatic 3-tetrafluoroethoxy substituents in trifluoro-3-(tertiaryamino)-2-propanols as potent inhibitors of cholesteryl ester transfer protein. Bioorg Med Chem Lett 11:1625-1628.
23. O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, et al. (2003) Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation 108:270-274.
24. Rao MN, Liu QH, Marmillot P, Seeff LB, Strader DB, Lakshman MR (2000) High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function. Metabolism 49:1406-1410.
25. Rye KA, Duong M, Psaltis MK, Curtiss LK, Bonnet DJ, Stocker R, Barter PJ (2002) Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling. Biochemistry 41:12538-12545.
26. Savolainen MJ, Hannuksela M, Seppänen S, Kervinen K, Kesäniemi YA (1990) Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest 20:593-599.
27. Swenson TL, Hesler CB, Brown ML, Quinet E, Trotta PP, Haslanger MF, et al. (1989) Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. J Biol Chem 264:14318-14326.
28. Tall A (1995) Plasma lipid transfer proteins. Annu Rev Biochem 64:235-257.
29. Tall AR (1980) Studies on the transfer of phosphatidylcholine from unilamellar vesicles into plasma high density lipoproteins in the rat. J Lipid Res 21:354-363.
30. van Tol A (2002) Phospholipid transfer protein. Curr Opin Lipidol 13:135-139.